Experimental MitoQ Treatment Fails Prevention of Age-Related Muscle Mass, Function Loss in Mice
Researchers used a long-term treatment approach of MitoQ (mitoquinone mesylate) in aging experimental mice, but the treatment had no beneficial effects on mitochondrial function or on muscle mass and function. The study, “Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of…